Lindenmayer J P
Manhattan Psychiatric Center-Nathan Kline Institute for Psychiatric Research, New York, NY 10035, USA.
J Clin Psychiatry. 2000;61 Suppl 14:5-10.
Agitation is a nonspecific constellation of relatively unrelated behaviors that can be seen in a number of different clinical conditions, usually presenting a fluctuating course. Multiple underlying pathophysiologic abnormalities are mediated by dysregulations of dopaminergic, serotonergic, noradrenergic, and GABAergic systems. Pathophysiologic mechanisms of agitation that operate in the different clinical disorders where agitation occurs are discussed. These pathophysiologic abnormalities are not associated with distinct clinical features. Although there may be a final common pathway, there is no unifying etiologic pathophysiology. The author suggests that the clinician address the underlying pathophysiology through a treatment intervention that addresses the overarching psychiatric disorder. Generally, agents that reduce dopaminergic or noradrenergic tone or increase serotonergic or GABAergic tone will attenuate agitation, often irrespective of etiology.
激越表现为一系列相对不相关行为的非特异性组合,可在多种不同临床状况中出现,通常呈现波动病程。多种潜在的病理生理异常由多巴胺能、5-羟色胺能、去甲肾上腺素能和γ-氨基丁酸能系统的失调介导。本文讨论了激越在不同临床疾病中发生时所涉及的病理生理机制。这些病理生理异常与独特的临床特征并无关联。尽管可能存在最终的共同通路,但不存在统一的病因病理生理学。作者建议临床医生通过针对总体精神障碍的治疗干预来处理潜在的病理生理学问题。一般来说,降低多巴胺能或去甲肾上腺素能张力或增加5-羟色胺能或γ-氨基丁酸能张力的药物通常会减轻激越,而往往与病因无关。